Literature DB >> 11837732

Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.

Mark I Hamilton1, Judy Sercombe, Roy E Pounder.   

Abstract

This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0-10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10-20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0-15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11837732     DOI: 10.1023/a:1013255201858

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Royal Free Hospital protocol for 24-hour intragastric acidity and plasma gastrin concentration.

Authors:  R E Pounder; S Lanzon-Miller; J T Smith; C Gavey; C U Nwokolo; E J Prewett; J Sercombe
Journal:  Dig Dis       Date:  1990       Impact factor: 2.404

2.  Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.

Authors:  T G Reilly; S G Mann; M Z Panos; R P Walt
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Prevention of heartburn relapse by low-dose famotidine: a test meal model for duration of symptom control.

Authors:  S G Mann; J Cottrell; A Murakami; L Stauffer; A N Rao
Journal:  Aliment Pharmacol Ther       Date:  1997-02       Impact factor: 8.171

4.  Day-to-day variation of 24-hour intragastric acidity.

Authors:  H S Merki; L Witzel; R P Walt; E Cohnen; K Harre; J Heim; A Mappes; J Röhmel
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

5.  Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.

Authors:  T G Reilly; S Singh; J Cottrell; S G Mann; L Stauffer; R P Walt
Journal:  Aliment Pharmacol Ther       Date:  1996-10       Impact factor: 8.171

Review 6.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.

Authors:  C E Grimley; J Cottrell; S G Mann; L Stauffer; C U Nwokolo
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

8.  Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.

Authors:  C E Grimley; S Constantinides; C C Snell; J G Mills; C U Nwokolo
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

9.  Low dose famotidine in the prevention of sleep disturbance caused by heartburn after an evening meal.

Authors:  S G Mann; A Murakami; K McCarroll; A N Rao; J Cottrell; J Mehentee; R Morton
Journal:  Aliment Pharmacol Ther       Date:  1995-08       Impact factor: 8.171

10.  Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects.

Authors:  S Bates; P O Sjödén; J Fellenius; O Nyrén
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

View more
  1 in total

1.  Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.

Authors:  Gerald Holtmann; Marc-André Bigard; Peter Malfertheiner; Roy Pounder
Journal:  Int J Clin Pharm       Date:  2011-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.